SCHEMBL11340707

SCHEMBL11340707

Cc1ccc(NC(=O)Nc2ccc(C)c(C(=O)Nc3cc(O)c4cccc(S(=O)(=O)O)c4c3)c2)cc1C(=O)Nc1cc(O)c2cccc(S(=O)(=O)O)c2c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 2/20 0.45
LCK P06239 1/20 0.45
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
POLB P06746 2/20 0.44
CA12 O43570 2/20 0.43
CA1 P00915 2/20 0.43
CA2 P00918 2/20 0.43
CA9 Q16790 2/20 0.43
PRMT1 Q99873 2/20 0.43
ALOX15 P16050 1/20 0.43
BRAF P15056 4/20 0.42
HPSE Q9Y251 2/20 0.42
CYP1A2 P05177 2/20 0.42
ENPP3 O14638 1/20 0.42
ENTPD3 O75355 1/20 0.42
NR1I2 O75469 1/20 0.42
USP2 O75604 1/20 0.42
PRKD3 O94806 1/20 0.42
TDP2 O95551 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10907979 0.93 BRAF (0.42) KDRLCKPOLBCA12CA1
SCHEMBL11349822 0.87 TNNI3 (0.46) KDRLCKMEN1KMT2APOLB
SCHEMBL11340787 0.85 PRMT1 (0.41) KDRLCKMEN1KMT2APOLB
SCHEMBL11339023 0.83 CA12 (0.47) KDRLCKMEN1KMT2APOLB
SCHEMBL11419061 0.83 TIMP3 (0.55) KDRMEN1KMT2APOLBPRMT1
SCHEMBL11341037 0.83 KMT2A (0.52) KDRLCKMEN1KMT2APOLB
SCHEMBL11344331 0.83 HPSE (0.47) KDRLCKMEN1KMT2APOLB
SCHEMBL11345079 0.83 HPSE (0.47) KDRLCKMEN1KMT2APRMT1
SCHEMBL11347423 0.82 TIMP3 (0.54) MEN1KMT2ACA1CA2PRMT1
SCHEMBL10823354 0.82 IDH1 (0.59) IDH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4297372-A ANTIARTHRITIC AGENTS; COLLAGENASE AND PROTEOLYTIC ENZYME INHIBITORS; BONE, SKIN, AND ORAL DISORDERS AMERICAN CYANAMID COMPANY (US) 1981-10-27 US disclosed
EP-0013784-A1 C-Substituted naphthalenemonosulfonic ureides, process for their preparation and pharmaceutical compositions containing them AMERICAN CYANAMID COMPANY (US) 1980-08-06 EP disclosed
US-4216164-A Ureide inhibitors of connective tissue destruction AMERICAN CYANAMID COMPANY (US) 1980-08-05 US disclosed